Exchange: OTC·Updated 10:32 AM EDT

IMVIQ IMV Inc

$0.00
$0.00
(0.00%)
Today
Reported EarningsMay 27
Vol1.00

About IMVIQ

IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.
0

Extremely Bearish Sentiment

How do you feel about IMVIQ?

Advertisement|Remove ads.